Moreover, STXBP1 encephalopathy may be characterized by a lack of improvement in developmental outcomes after seizures have subsided, and it is necessary to explain to patients and their families that anti-epileptic drug therapy, such as ACTH therapy has significant side effects and cannot be expected to improve developmental outcomes. The gene discussed is POMC; the disease is Encephalopathy.